Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Explore which bonds are most tax efficient in retirement and how they affect withdrawals. Learn strategies to minimize taxes and boost after-tax income.
25,089 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
As July opens, bitcoin nears final stage of its bear market window, with prices holding steady and institutional infl...
Publicly traded crypto firms rose 23% in the first half of 2026 while crypto assets declined 36%, widening the gap to...
Oil prices hovered near $86 per barrel early today, with Brent as the benchmark. Markets weigh demand signals, supply...
A viral moment at Wrigley Field sparked questions about safety and money. This guide shows smart budgeting, risk chec...
Oklo has zigzagged from a peak near $193 to much lower levels, raising questions about its momentum and prospects. Th...
Four families claim Amazon sold sodium nitrite despite safety concerns, pushing the lawsuit against amazon over towar...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...
When top tech names dip after a sell-off, history says time these moments can unlock long-term gains. This guide brea...
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
As 2026 unfolds, a new government analysis finds that majors tied to real-world demand offer strong pay and job stabi...